Work

Characteristics and Clinical Outcomes of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Who Received At Least 3 Lines of Therapies

FWCI: 0.836
Cites: 17
Cited by: 7
Related to: 10